Andrew Aldridge: Why EIS is so Vital to the Health of the NHS
- On February 7, 2019
- By GrowthInvest Admin
Much of the research, development and innovation necessary to make the government’s new long-term plan for the NHS a reality will be driven by private ventures and early-stage companies, argues Andrew Aldridge
It might not have garnered many headlines, given what has been happening in Parliament around the UK’s withdrawal from the EU, but amidst the ongoing Brexit debate, the government recently launched its NHS Long Term Plan. I doubt there has been much coverage within the financial services press about this plan either – yet it could yield further future opportunity for UK investors.
According to the government, the Long-Term Plan is designed “to improve the quality of patient care and health outcomes” and, in that sense, it may well deliver some much-needed certainty for the health service. Last year the government announced £20.5bn of funding for the NHS, and this plan sets out how it will be spent over the next five years.
GET IN TOUCH!
CALL US020 7071 3945
FOLLOW US ON
Throughout our site you will find links to external websites. Although we make every effort to ensure these links are accurate, up to date and relevant, we cannot take responsibility for pages maintained by external providers.